James Hassard compensation by year
Crinetics Pharmaceuticals Summary Compensation Table · the one fiscal year held| Component | FY2023 |
|---|---|
| Salary | $436,667 |
| Bonus | $0 |
| Stock awards | $274,960 |
| Option awards | $807,143 |
| Non-equity incentive | $183,837 |
| Pension and deferred compensation | $0 |
| All other | $3,000 |
| Total | $1,705,607 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Crinetics Pharmaceuticals, Inc. DEF 14A filed April 25, 2024, accession 0000950170-24-048438, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Crinetics Pharmaceuticals, Inc. filed document, accession 0000950170-24-048438. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.
Crinetics Pharmaceuticals’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| R. Scott Struthers | President and Chief Executive Officer | $5,747,994 |
| Marc Wilson | Former Chief Financial Officer | $2,513,495 |
| Stephen Betz | Chief Scientific Officer | $2,496,868 |
| Jeff Knight | Chief Operating Officer | $2,362,362 |
| Alan Krasner | Chief Endocrinologist | $2,162,574 |
| James Hassard · this page | Chief Commercial Officer | $1,705,607 |
| Dana Pizzuti | Chief Medical Officer | $1,102,038 |
The full Crinetics Pharmaceuticals compensation record
free company briefThis page is one person within Crinetics Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Crinetics Pharmaceuticals proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Crinetics Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.